Reference intervals for carcinoembryonic antigen (CEA), CA125, MUC1, Alfa‐foeto‐protein (AFP), neuron‐specific enolase (NSE) and CA19.9 from the NORIP study

References

• Rustad P., Felding P., Franzson L., Kairisto V., Lahti A., Martensson A., et al. The Nordic Reference Interval Project 2000: recommended reference intervals for 25 common biochemical properties. Scand J Clin Lab Invest 2004; 64: 271–84
   PubMed Web of Science ®Google Scholar
• Rustad P., Simonsson P., Felding P., Pedersen M. Nordic Reference Interval Project Bio‐bank and Database (NOBIDA): a source for future estimation and retrospective evaluation of reference intervals. Scand J Clin Lab Invest 2004; 64: 431–8
   PubMed Web of Science ®Google Scholar
• PetitClerc C., Solberg H. E. International Federation of Clinical Chemistry (IFCC). Expert Panel on theory of reference values. Approved recommendation (1987) on the theory of reference values. Part 2. Selection of individuals for the production of reference values. J Clin Chem Clin Biochem 1987; 25: 639–44
   Google Scholar
• Solberg H. E., PetitClerc C. International Federation of Clinical Chemistry (IFCC), Scientific Committee, Clinical Section, Expert Panel on Theory of Reference Values. Approved recommendation (1988) on the theory of reference values. Part 3. Preparation of individuals and collection of specimens for the production of reference values. J Clin Chem Clin Biochem 1988; 26: 593–8
   PubMedGoogle Scholar
• Solberg H. E., Stamm D. International Federation of Clinical Chemistry, Scientific Division: approved recommendation on the theory of reference values. Part 4. Control of analytical variation in the production, transfer and application of reference values. Eur J Clin Chem Clin Biochem 1991; 29: 531–5
   PubMedGoogle Scholar
• Solberg H. E. International Federation of Clinical Chemistry (IFCC), Scientific Committee, Clinical Section, Expert Panel on Theory of Reference Values, and International Committee for Standardization in Haematology (ICSH), Standing Committee on Reference Values. Approved Recommendation (1986) on the theory of reference values. Part 1. The concept of reference values. J Clin Chem Clin Biochem 1987; 25: 337–42
   PubMedGoogle Scholar
• Solberg H. E. International Federation of Clinical Chemistry (IFCC) and International Committee for Standardization in Haematology (ICSH). Approved recommendation (1987) on the theory of reference values. Part 5. Statistical treatment of collected reference values. Determination of reference limits. J Clin Chem Clin Biochem 1987; 25: 645–56
   Google Scholar
• Dybkaer R., Solberg H. E. International Federation of Clinical Chemistry (IFCC) and International Committee for Standardization in Haematology (ICSH). Approved recommendation (1987) on the theory of reference values. Part 6. Presentation of observed values related to reference values. J Clin Chem Clin Biochem 1987; 25: 657–62
   Google Scholar
• Rustad P., Felding P., Lahti A. Proposal for guidelines to establish common biological reference intervals in large geographical areas for biochemical quantities measured frequently in serum and plasma. Clin Chem Lab Med 2004; 42: 783–91
   PubMed Web of Science ®Google Scholar
• Bjerner J. Age‐dependent biochemical quantities: an approach for calculating reference intervals. Scand J Clin Lab Invest 2007; 67: 707–22
   PubMed Web of Science ®Google Scholar
• Pedersen M. M., Rustad P., Simonsson P. Certificate of analysis NFKK Reference Serum X: a reprint. Scand J Clin Lab Invest 2004; 64: 321–6
   PubMed Web of Science ®Google Scholar
• Bjerner J., Nustad K., Norum L. F., Olsen K. H., Bormer O. P. Immunometric assay interference: incidence and prevention. Clin Chem 2002; 48: 613–21
   PubMed Web of Science ®Google Scholar
• Børmer O. P., Nustad K. Selection of monoclonal antibodies for use in an immunometric assay for carcinoembryonic antigen. J Immunol Methods 1990; 127: 171–8
   PubMed Web of Science ®Google Scholar
• Hammarström S., Shively J. E., Paxton R. J., Beatty B. G., Larsson Å., Ghosh R., et al. Antigenic sites in carcinoembryonic antigen. Cancer Res 1989; 49: 4852–8
   PubMed Web of Science ®Google Scholar
• Børmer O. A direct assay for carcinoembryonic antigen in serum and its diagnostic value in metastatic breast cancer. Clin Biochem 1982; 15: 128–32
   PubMed Web of Science ®Google Scholar
• Paus E., Almåsbak H., Børmer O. P., Warren D. J. A single‐chain Fv based immunofluorometric assay specific for the CEA variant NCA‐2. J Immunol Methods 2003
   PubMed Web of Science ®Google Scholar
• Laurence D. J. R., Turberville C., Anderson S. G., Neville A. M. First British standard for carcinoembryonic antigen (CEA). Br J Cancer 1975; 32: 295–9
   PubMed Web of Science ®Google Scholar
• Bjorge T., Lie A. K., Hovig E., Gislefoss R. E., Hansen S., Jellum E., et al. BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case‐control study. Br J Cancer 2004; 91: 1829–34
   PubMed Web of Science ®Google Scholar
• Nustad K., Bast R. C. J., O'Brien T. J., Nilsson O., Seguin P., Suresh M. R., et al. Specificity and affinity of 26 monoclonal antibodies against the CA 125 antigen: first report from the ISOBM TD‐1 workshop. Tumor Biol 1996; 17: 196–219
   PubMed Web of Science ®Google Scholar
• Bjerner J., Norum L. F., Nilsson O., Nustad K. MUC1 serum assays in breast cancer: tumor specificities and reference levels. Tumour Biol 2002; 23: 315–23
   PubMedGoogle Scholar
• Suonpaa M. U., Lavi J. T., Hemmila I. A., Lovgren T. N. A new sensitive assay of human alpha‐fetoprotein using time‐resolved fluorescence and monoclonal antibodies. Clin Chim Acta 1985; 145: 341–8
   PubMed Web of Science ®Google Scholar
• Paus E., Nustad K. Immunoradiometric assay for alpha gamma‐ and gamma gamma‐enolase (neuron‐specific enolase), with use of monoclonal antibodies and magnetizable polymer particles. Clin Chem 1989; 35: 2034–8
   PubMed Web of Science ®Google Scholar
• Paus E., Risberg T. Establishment and evaluation of a radioimmunoassay for neuron‐ specific enolase. A marker for small cell lung cancer. Tumour Biol 1989; 10: 23–30
   PubMedGoogle Scholar
• R Development Core Team. R: A language and environment for statistical computing. 2007, R Foundation for Statistical Computing, Vienna, Austria
   Google Scholar
• Lahti A., Hyltoft P. P., Boyd J. C., Fraser C. G., Jorgensen N. Objective criteria for partitioning Gaussian‐distributed reference values into subgroups. Clin Chem 2002; 48: 338–52
   PubMed Web of Science ®Google Scholar
• Tietz textbook of clinical chemistry, 4th edn. W. B. Saunders, Los Angeles, Calif 2005
   Google Scholar
• Stevens D. P., Mackay I. R. Increased carcinoembryonic antigen in heavy cigarette smokers. Lancet 1973; 2: 1238–9
   PubMed Web of Science ®Google Scholar
• Alexander J. C., Silverman N. A., Chretien P. B. Effect of age and cigarette smoking on carcinoembryonic antigen levels. J Am Med Assoc 1976; 235: 1975–9
   PubMed Web of Science ®Google Scholar
• Børmer O. P. Major disagreement between immunoassays of carcinoembryonic antigen may be caused by nonspecific cross‐reacting antigen 2 (NCA‐2). Clin Chem 1991; 37: 1736–9
   PubMed Web of Science ®Google Scholar
• Bjerner J., Lebedin Y., Bellanger L., Kuroki M., Shively J. E., Varaas T., et al. Protein epitopes in carcinoembryonic antigen. Report of the ISOBM TD8 workshop. Tumour Biol 2002; 23: 249–62
   PubMedGoogle Scholar
• Paus E., Almasbak H., Bormer O. P., Warren D. J. A single‐chain‐Fv‐based immunofluorometric assay specific for the CEA variant NCA‐2. J Immunol Methods 2003; 283: 125–39
   PubMed Web of Science ®Google Scholar
• Lopez L. A., Del V., Ulla M., Fernandez F., Fernandez L. A., Santos I., et al. Prevalence of abnormal levels of serum tumour markers in elderly people. Age Ageing 1996; 25: 45–50
   PubMed Web of Science ®Google Scholar
• Gendler S. J., Lancaster C. A., Taylor‐Papadimitriou J., Duhig T., Peat N., Burchell J., et al. Molecular cloning and expression of human tumor‐associated polymorphic epithelial mucin. J Biol Chem 1990; 265: 15286–93
   PubMed Web of Science ®Google Scholar
• Ball D., Rose E., Alpert E. Alpha‐fetoprotein levels in normal adults. Am J Med Sci 1992; 303: 157–9
   PubMed Web of Science ®Google Scholar
• Paus E., Myklebust A. T. Expression and interconversion of NSE in patient sera and extracts from small cell lung cancer cells. Tumor Biol 1996
   Google Scholar
• Kulpa J., Wojcik E., Reinfuss M., Kolodziejski L. Carcinoembryonic antigen, squamous cell carcinoma antigen, CYFRA 21‐1, and neuron‐specific enolase in squamous cell lung cancer patients. Clin Chem 2002; 48: 1931–7
   PubMed Web of Science ®Google Scholar
• Jorgensen L. G., Lober J., Carlsen N. L., Momsen G., Hirsch F. R. Serum neuron specific enolase (S‐NSE) reference interval evaluation by time‐resolved immunofluorometry compared with a radioimmunoassay. Clin Chim Acta 1996; 249: 77–91
   PubMed Web of Science ®Google Scholar
• Passerini R., Riggio D., Salvatici M., Zorzino L., Radice D., Sandri M. T. Interchangeability of measurements of CA 19‐9 in serum with four frequently used assays: an update. Clin Chem Lab Med 2007; 45: 100–4
   PubMed Web of Science ®Google Scholar
• Vestergaard E. M., Hein H. O., Meyer H., Grunnet N., Jorgensen J., Wolf H., et al. Reference values and biological variation for tumor marker CA 19‐9 in serum for different Lewis and secretor genotypes and evaluation of secretor and Lewis genotyping in a Caucasian population. Clin Chem 1999; 45: 54–61
   PubMed Web of Science ®Google Scholar
• Horn P. S., Feng L., Li Y., Pesce A. J. Effect of outliers and nonhealthy individuals on reference interval estimation. Clin Chem 2001; 47: 2137–45
   PubMed Web of Science ®Google Scholar